ArticleArchives of endocrinology and metabolism

Safety and efficacy of sorafenib in patients with advanced thyroid carcinoma: a phase II study (NCT02084732).

Luis Felipe Fierro-Maya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.